These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. A history of the development of narcotic antagonists for the treatment of narcotic addiction. Martin WR NIDA Res Monogr; 1978; (19):296-300. PubMed ID: 218106 [No Abstract] [Full Text] [Related]
12. Narcotic antagonists in the treatment of opiate dependence. Fink M; Zaks A; Resnick RB; Freedman AM Int Z Klin Pharmakol Ther Toxikol; 1971 Jun; 4(4):455-8. PubMed ID: 5566728 [No Abstract] [Full Text] [Related]
13. Naloxone reversal of methadone poisoning. Buchner LH; Cimino JA; Raybin HW; Stewart B N Y State J Med; 1972 Sep; 72(18):2305-9. PubMed ID: 4506881 [No Abstract] [Full Text] [Related]
14. The use of drugs in the management of drug dependence. Eddy NB J Tenn Med Assoc; 1967 Mar; 60(3):269-73. PubMed ID: 6042204 [No Abstract] [Full Text] [Related]
15. Clinical studies of cyclazocine in the treatment of narcotic addiction. Freedman AM; Fink M; Sharoff R; Zaks A Am J Psychiatry; 1968 May; 124(11):1499-504. PubMed ID: 4869436 [No Abstract] [Full Text] [Related]
16. Certain theoretical and practical considerations involved in evaluating the overall abuse potential of opiate agonists and antagonists. Fraser HF Adv Biochem Psychopharmacol; 1973; 8(0):439-53. PubMed ID: 4604198 [No Abstract] [Full Text] [Related]
17. The use of cyclazocine in the treatment of heroin addicts. Petursson ES; Preble E Dis Nerv Syst; 1970 Aug; 31(8):549-51. PubMed ID: 5471792 [No Abstract] [Full Text] [Related]
18. Buprenorphine and naloxone interactions in methadone maintenance patients. Mendelson J; Jones RT; Welm S; Brown J; Batki SL Biol Psychiatry; 1997 Jun; 41(11):1095-101. PubMed ID: 9146820 [TBL] [Abstract][Full Text] [Related]
19. Naloxone treatment of opiate dependence. A progress report. Zaks A; Jones T; Fink M; Freedman AM JAMA; 1971 Mar; 215(13):2108-10. PubMed ID: 5108223 [No Abstract] [Full Text] [Related]